methods to monitor a bladder cancer patient and to treat a bladder cancer patient, system to quantify dna methylation, cartridge, kit and composition

摘要

the present disclosure refers to methods of monitoring patients with bladder cancer and analyzing patient samples for the presence of methylated DNA and optionally for specific genetic mutations. in some examples, the results of the analysis are correlated with clinical outcome measures, such as the risk of bladder cancer recurrence.